ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732825; 2) Community: the network communities that were significantly associated with the response to NSC 732825; 3) Molecule: the relationships between components within communities and NSC 732825; 4) MDR: the compounds that were significantly associated with the NSC 732825.

NSC Compound Enrichment Correlation
NSC 644916 ANTINEOPLASTIC-644916 0.000455867606843419 0.43568328
NSC 673421 Null 0.000455867606843419 0.48659515
NSC 684569 Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- 0.000455867606843419 0.35091863
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.000455867606843419 0.45827284
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.000644707050513007 0.40163102
NSC 652536 Null 0.000644707050513007 0.47533028
NSC 718165 Null 0.000644707050513007 0.48751586
NSC 727224 1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline 0.000644707050513007 0.64602587
NSC 742544 Naphth[1',2':4,5]imidazo[1,2-a]pyridine-5,6-dione, 9-chloro- 0.000837923650101952 0.36117516
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.000837923650101958 0.58370352
Total:91  Current:3    [First] [Prev] [Next] [Last]